Study author
|
Year
|
Country
|
Study setting
|
Prognostic or diagnostic
|
N
|
Sepsis definition
|
PC assay
|
Prognostic outcome
|
Diagnostic outcome
|
---|
Chornenki [28]
|
2020
|
Canada
|
MC, ICU
|
Diagnostic
|
357
|
Sepsis-3
|
ELISA
|
–
|
Sepsis + DIC
|
Masuda [27]
|
2020
|
Japan
|
SC, ED
|
Diagnostic
|
107
|
Sepsis-1
|
–
|
–
|
Sepsis + DIC
|
Ishikura [29]
|
2014
|
Japan
|
SC, ED
|
Diagnostic
|
84
|
Sepsis-1
|
Coagulation Analyzer
|
–
|
Sepsis
|
Mihajlovic [30]
|
2016
|
Serbia
|
SC, ED, IDC
|
Prognostic
|
150
|
Sepsis-2
|
Coagulation Analyzer
|
28-day mortality
|
–
|
Dwivedi [31]
|
2012
|
Canada
|
MC, ICU
|
Prognostic
|
80
|
Sepsis-2
|
ELISA
|
Mortality
|
–
|
Umemura [32]
|
2016
|
Japan
|
SC, ED
|
Both
|
79
|
Sepsis-1
|
Coagulation Analyzer
|
Mortality
|
Sepsis + DIC
|
Liaw [33]
|
2019
|
Canada
|
MC, ICU
|
Prognostic
|
356
|
Sepsis-3
|
ELISA
|
28-day mortality
|
–
|
Lorente [34]
|
1993
|
Spain
|
ICU
|
Both
|
48
|
Sepsis-1
|
Immunoelectro-phoresis
|
28-day mortality
|
Septic shock
|
Walborn [35]
|
2020
|
USA
|
ICU
|
Both
|
103
|
Sepsis-1
|
Coagulation Analyzer
|
28-day mortality
|
Sepsis + DIC
|
Koyama [36]
|
2014
|
Japan
|
SC, ICU
|
Both
|
77
|
Sepsis-2
|
Coagulation Analyzer
|
28-day mortality
|
Sepsis + DIC
|
Shapiro [37]
|
2009
|
USA
|
MC, ED
|
Both
|
971
|
Sepsis-1
|
ELISA
|
In-hospital mortality
|
Severe Sepsis
|
Karamarkovic [38]
|
2005
|
Serbia
|
SC
|
Both
|
59
|
Sepsis-1
|
Coagulation Analyzer
|
Mortality
|
Surgical sepsis
|
- MC multicenter, SC single center, ED emergency department, ICU intensive care unit, IDC infectious disease clinic, DIC disseminated intravascular coagulation